BIOMAT Database Logo BIOMAT Database Logo

Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens. 1992

P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Garvan Institute of Medical Research, St. Vincent's Hospital, University of New South Wales, Sydney, Australia.

Osteoporosis is a frequent complication of rheumatoid arthritis (RA), especially in postmenopausal women, and may involve both juxtaarticular and generalized bone loss. To examine the effect of exogenous estrogens and endogenous androgens on bone loss in RA we determined rates of bone loss by serial bone density measurement for up to 4 years in 38 postmenopausal women with RA. Serum dehydroepiandosterone sulfate concentrations correlated significantly with the change in femoral neck bone but not in lumbar spine bone. Estrogen therapy prevented lumbar spine bone loss, but did not affect bone loss from the hip. These data suggest adrenal androgen status may influence bone loss in RA and that, although estrogen therapy can prevent bone loss from the spine, it may not prevent bone loss at sites near involved joints.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006621 Hip Joint The joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS. Acetabulofemoral Joint,Acetabulofemoral Joints,Hip Joints,Joint, Acetabulofemoral,Joint, Hip,Joints, Acetabulofemoral,Joints, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013131 Spine The spinal or vertebral column. Spinal Column,Vertebrae,Vertebral Column,Vertebra,Column, Spinal,Column, Vertebral,Columns, Spinal,Columns, Vertebral,Spinal Columns,Vertebral Columns
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
[Postmenopausal bone loss. Role of estrogens].
May 1992, Presse medicale (Paris, France : 1983),
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
[Postmenopausal bone loss. Role of progesterone and androgens].
June 1992, Presse medicale (Paris, France : 1983),
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.
December 1977, Annals of internal medicine,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis.
June 2002, Annals of the New York Academy of Sciences,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis.
November 1996, Annals of the rheumatic diseases,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Estrogens in rheumatoid arthritis; the immune system and bone.
March 2011, Molecular and cellular endocrinology,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Androgens, estrogens, and bone in men.
December 2000, Annals of internal medicine,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Role of estrogens in the management of postmenopausal bone loss.
February 2001, Rheumatic diseases clinics of North America,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Androgens and estrogens in postmenopausal insulin-treated diabetic women.
November 1989, The Journal of clinical endocrinology and metabolism,
P Sambrook, and J Birmingham, and D Champion, and P Kelly, and S Kempler, and J Freund, and J Eisman
Prevention of postmenopausal bone loss in rheumatoid arthritis patients. A two-year prospective study.
January 1989, Clinical and experimental rheumatology,
Copied contents to your clipboard!